Subject | Annexin | H2A.X | DNA-X | ROS | NO | Live cells | P13 | EGFR | Ki67 | MAPK | BCL-2 |
S#1 B 13 d | 25% | 29% | 14.8% | 0.6% | 4.2% | 0.11 | 8% | 5.3% | 3.8% | 4.8% | 2.5% |
C 18 d | 23.3% | 33.6% | 10.5% | 0% | 4.9% | 0.22 | 6% | 4.4% | 2.7% | 3.4% | 1.1% |
C-PF 18 d | 12.2% | 17.5% | 10.5% | 0.1% | 4.1% | 0.48 | 3.1% | 2% | 2% | 2% | 0.4% |
G18 d | 30.3% | 48.3% | 10.7% | 0% | 12.7% | 0.08 | 6.3% | 3.4% | 5.3% | 8.9% | 5.2% |
G-PF 18 d | 2.7% | 17% | 13.9% | 0.3% | 9.6% | 0.25 | 1% | 0.8% | 1.8% | 1.3% | 3.1% |
S#5 B 20 d | 8.4% | 11.9% | 5.6% | 0.1% | 2.8% | 0.11 | 3.8% | 2.4% | 2.8% | 1.6% | 1.9% |
C 25 d | 6.2% | 24.5% | 20.9% | 0.2% | 12.6% | 0.09 | 5.1% | 2% | 3.3% | 9.7% | 7.2% |
C-PF 25 d | 1.8% | 14.9% | 16.4% | 0.1% | 1.3% | 0.21 | 0.8% | 0.5% | 1.1% | 2% | 1.9% |
G 25 d | 7.2% | 37.8% | 27.3% | 0.6% | 14.6% | 0.15 | 7.6% | 4.2% | 2.1% | 7.1% | 4.9% |
G-PF 25 d | 3.8% | 29.4% | 29.8% | 0% | 9.6% | 0.18 | 5.4% | 1.2% | 1.9% | 4.2% | 1.8% |
S#6 B 8 d | 27% | 59.2% |
|
|
| 0.23 | 11.6% | 0.9% |
|
|
|
C 11 d | 40.1% | 81.4% |
|
|
| 0.19 | 16.2% | 5.8% |
|
|
|
G 11 d | 43.1% | 81.3% |
|
|
| 0.09 | 21.5% | 8.8% |
|
|
|
G-PF 11 d | 44% | 40.7% |
|
|
| 0.27 | 2.8% | 2% |
|
|
|
C 14 d | 57.6% | 75.6% |
|
|
| 0.08 | 25.5% | 17.4% |
|
|
|
G 14 d | 72.3% | 89.5% |
|
|
| 0.05 | 34.4% | 19.2% |
|
|
|
G-PF 14 d | 24.6% | 36.1% |
|
|
| 0.22 | 5.5% | 3.7% |
|
|
|